Product name:Roflumilast

Chemicalname:3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide

CAS No.:162401-32-3

Specification:99.0%HPLC

MolecularFormula:C17H14Cl2F2N2O3

Appearance: white powder

Usage:On March 1,2011, the FDA approved the chronic obstructivepneumonia drug Daliresp (roflumilast), the drug used daily, canreduce asthma attack frequency or mitigate serious chronicobstructive pneumonia (COPD) symptoms.Roflumilast is a new categoryof COPD drug, phosphodiesterase - 4 (PDE - 4) inhibitors. Can beused among patients with serious COPD cough andbronchial symptom related much sputum, does not apply tomild emphysema.